| Dr Shachar Kenan, MD | |
|
270-05 76th Ave, New Hyde Park, NY 11040-1402 | |
| (718) 470-7000 | |
| Not Available |
| Full Name | Dr Shachar Kenan |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 270-05 76th Ave, New Hyde Park, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285078246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2836881 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Long Island Jewish Medical Center | New hyde park, NY | Hospital |
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Medical Pc | 3375701568 | 5099 |
| Parker Jewish Institute For Health Care And Rehabilitation | 5294645966 | 4 |
News Archive
The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.
Research news published in Criminal Behaviour and Mental Health drew two main findings from a survey of rugby supporters entering and leaving the Millennium Stadium in Cardiff: spectators in the winning and drawing groups rated themselves as more aggressive than those whose team just lost; and more aggressive spectators intended to drink more alcohol after the match.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
› Verified 7 days ago
| Entity Name | Parker Jewish Institute For Health Care And Rehabilitation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932275427 PECOS PAC ID: 5294645966 Enrollment ID: O20040223000631 |
News Archive
The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.
Research news published in Criminal Behaviour and Mental Health drew two main findings from a survey of rugby supporters entering and leaving the Millennium Stadium in Cardiff: spectators in the winning and drawing groups rated themselves as more aggressive than those whose team just lost; and more aggressive spectators intended to drink more alcohol after the match.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
› Verified 7 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.
Research news published in Criminal Behaviour and Mental Health drew two main findings from a survey of rugby supporters entering and leaving the Millennium Stadium in Cardiff: spectators in the winning and drawing groups rated themselves as more aggressive than those whose team just lost; and more aggressive spectators intended to drink more alcohol after the match.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shachar Kenan, MD 270-05 76th Ave, New Hyde Park, NY 11040-1402 Ph: (718) 470-7000 | Dr Shachar Kenan, MD 270-05 76th Ave, New Hyde Park, NY 11040-1402 Ph: (718) 470-7000 |
News Archive
The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.
Research news published in Criminal Behaviour and Mental Health drew two main findings from a survey of rugby supporters entering and leaving the Millennium Stadium in Cardiff: spectators in the winning and drawing groups rated themselves as more aggressive than those whose team just lost; and more aggressive spectators intended to drink more alcohol after the match.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
› Verified 7 days ago
Alexander Volpi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2800 Marcus Ave Ste 102, New Hyde Park, NY 11042 Phone: 914-260-5459 | |
John E Handelsman, M.D.,FRCS,MCH.ORTH Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1999 Marcus Ave Ste 200, New Hyde Park, NY 11042 Phone: 516-467-8600 | |
Dr. Allison Brooke Spitzer, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 7 Vermont Drive, Center For Pediatric Orthopaedic Surgery, New Hyde Park, NY 11042 Phone: 516-210-8400 | |
Maury Harris, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Road, Suite 209, New Hyde Park, NY 11042 Phone: 516-358-2121 | |
Raymond A Shebairo, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1575 Hillside Ave, Ste 303, New Hyde Park, NY 11040 Phone: 516-437-5500 Fax: 516-358-5359 | |
Dr. Kenneth Mark Kamler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, Suite 100, New Hyde Park, NY 11042 Phone: 516-326-8810 Fax: 516-328-7165 |